Bottom line
SWHFX vs SCHLX: the short answer
SWHFX (Schwab Health Care Fund) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 71% by weight.
SWHFX is cheaper at 0.8% vs 1.06% — a difference of $26 a year per $10,000 invested.
Updated Nov 19, 2026
SWHFX vs SCHLX side by side
| SWHFX | SCHLX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Schwab | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.8% | 1.06% |
| Annual cost per $10k | $80 | $106 |
| 10-yr cost on $10k (prospectus) | $990 | $1,294 |
| Max front load | — | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +15.9% | — |
| 5-yr return (annualized) | +6.5% | — |
| 10-yr return (annualized) | +8.1% | — |
| Best quarter | +15.3% | — |
| Worst quarter | −12.1% | — |
| Net assets (fund) | $642.3M | $231.8M |
| Number of holdings | 80 | 65 |
| Portfolio turnover | 41% | 2% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
16 of SWHFX's top 25 holdings also appear in SCHLX's top 25.
| Holding | SWHFX | SCHLX |
|---|---|---|
| Eli Lilly & Co | 13.92% | 13.85% |
| Johnson & Johnson | 6.94% | 6.19% |
| AbbVie Inc | 5.81% | 4.90% |
| Merck & Co Inc | 4.98% | 4.85% |
| UnitedHealth Group Inc | 4.74% | 5.73% |
| Gilead Sciences Inc | 3.24% | 2.78% |
| Amgen Inc | 2.58% | 2.88% |
| Bristol-Myers Squibb Co | 2.44% | 1.50% |
| Medtronic PLC | 2.29% | 1.54% |
| Roche Holding AG | 2.29% | 1.24% |
| Thermo Fisher Scientific Inc | 2.16% | 3.46% |
| Stryker Corp | 2.11% | 2.61% |
| Vertex Pharmaceuticals Inc | 1.89% | 2.45% |
| Boston Scientific Corp | 1.60% | 2.10% |
| Abbott Laboratories | 1.60% | 2.39% |
Source: SEC Form N-PORT
SWHFX top 10
- Eli Lilly & Co — 13.92%
- Johnson & Johnson — 6.94%
- AbbVie Inc — 5.81%
- Merck & Co Inc — 4.98%
- UnitedHealth Group Inc — 4.74%
- Gilead Sciences Inc — 3.24%
- Novartis AG — 2.92%
- Amgen Inc — 2.58%
- Bristol-Myers Squibb Co — 2.44%
- Medtronic PLC — 2.29%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between SWHFX and SCHLX?
SWHFX (Schwab Health Care Fund) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 71% by weight. SWHFX is cheaper at 0.8% vs 1.06% — a difference of $26 a year per $10,000 invested.
Which is cheaper, SWHFX or SCHLX?
SWHFX has the lower expense ratio (0.8%).
Should I own both SWHFX and SCHLX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.